Baseline use of aspirin or statins with oral estrogen and progestogens to prevent incident arterial or venous thrombotic events: a secondary analysis of the Women's Health Initiative trial.

Saved in:
Bibliographic Details
Title: Baseline use of aspirin or statins with oral estrogen and progestogens to prevent incident arterial or venous thrombotic events: a secondary analysis of the Women's Health Initiative trial.
Authors: Davis JW; Department of Medicine, Washington University in St. Louis, 1 Barnes Jewish Hospital, St. Louis, MO., Aragaki AK; Division of Public Health Sciences, Fred Hutchinson Cancer Center., Harrington LB; Kaiser Permanente Washington Health Research Institute.; Department of Epidemiology, University of Washington School of Public Health, Seattle, WA.; Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA., Rossouw JE; Division of Cardiovascular Sciences, National Heart, Lung and Blood Institute, Bethesda, MD., Wells G; Division of Cardiovascular Diseases, Department of Internal Medicine, University of Alabama Birmingham Heersink School of Medicine, Birmingham, AL., Shadyab A; Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, La Jolla, CA.; Department of Medicine, Division of Geriatrics, Gerontology and Palliative Care, University of California San Diego, La Jolla, CA., Schnatz PF; Departments of OB-Gyn and Medicine, Drexel University, Reading, PA., Shufelt CL; Division of General Internal Medicine, Department of Medicine, Mayo Clinic.; Mayo Clinic Women's Health, Mayo Clinic, Jacksonville, FL., Warsinger-Martin L; Department of Medicine, George Washington University School of Medicine, Washington DC., Wild RA; Department of OB/GYN, Oklahoma University Health Sciences Center, Reproductive Endocrinology, and Department of Biostatistics and Epidemiology, College of Medicine, Oklahoma, OK., Manson JE; Division of Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, Harvard T.H. Chan School of Public Health, Boston, MA.
Source: Menopause (New York, N.Y.) [Menopause] 2026 Feb 01; Vol. 33 (2), pp. 134-144. Date of Electronic Publication: 2026 Feb 01.
Publication Type: Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Lippincott-Raven Publishers Country of Publication: United States NLM ID: 9433353 Publication Model: Electronic Cited Medium: Internet ISSN: 1530-0374 (Electronic) Linking ISSN: 10723714 NLM ISO Abbreviation: Menopause Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1530-0374
DOI:10.1097/GME.0000000000002647